4.6 Article

HPLC and HPTLC assays for the antimalarial agents Chloroquine, Primaquine and Bulaquine

Journal

JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
Volume 33, Issue 4, Pages 851-858

Publisher

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/S0731-7085(03)00355-8

Keywords

antirelapse; antimalarial; Bulaquine; Primaquine; Chloroquine; simultaneous estimation; HPLQ; HPTLC

Ask authors/readers for more resources

A combination Kit for antirelapse treatment of P. vivax malaria, consisting of Chloroquine phosphate tablets and Bulaquine capsules has been recently developed, and marketed under the trade name Aablaquine. Bulaquine is prepared from Primaquine. Several methods of analysis are reported for each drug separately as well two drugs in combination but no method for simultaneous estimation of these three drugs is known. Therefore, the present study was undertaken to develop a sensitive and reproducible high performance liquid chromatographic as well as high performance thin layer chromatographic assay method for the simultaneous estimation of Chloroquine, Primaquine and Bulaquine. (C) 2003 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available